A carregar...
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study
Background/Aim: Chronic myeloid leukaemia (CML) rarely affects the paediatric population and has an incidence of 0.06-0.12/100,000 children per year. The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy. Patients and Methods: Our coho...
Na minha lista:
| Publicado no: | In Vivo |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Institute of Anticancer Research
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559902/ https://ncbi.nlm.nih.gov/pubmed/31028210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11552 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|